| 1. |
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27(5): 1047-1053.
|
| 2. |
Marble A. Diabetes and cancer. New Engl J Med, 1934, 211: 339-349.
|
| 3. |
Ling S, Brown K, Miksza JK, et al. Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people. Diabetes Care, 2020, 43(9): 2313-2322.
|
| 4. |
Yuan S, Kar S, Carter P, et al. Is type 2 diabetes causally associated with cancer risk. Evidence from a two-sample mendelian randomization study. Diabetes, 2020, 69(7): 1588-1596.
|
| 5. |
Ballotari P, Vicentini M, Manicardi V, et al. Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy. BMC Cancer, 2017, 17(1): 703.
|
| 6. |
He X, Shi L, Wu J. Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China. Curr Med Res Opin, 2018, 34(6): 1089-1098.
|
| 7. |
Linkeviciute-Ulinskiene D, Patasius A, Zabuliene L, et al. Increased risk of site-specific cancer in people with type 2 diabetes: a national cohort study. Int J Environ Res Public Health, 2019, 17(1): 246.
|
| 8. |
吴坚坚, 方针强, 贾维胜, 等. 2型糖尿病与肾癌发病风险的Meta分析. 局解手术学杂志, 2015, 24(3): 307-310.
|
| 9. |
王佳斌, 魏莉莉, 王蒙, 等. 镉与儿童孤独症相关性的Meta分析. 中国循证医学杂志, 2020, 20(6): 702-707.
|
| 10. |
宋毅杰, 陈楠, 王子淮, 等. 经气腔内播散与肺腺癌临床病理特征及预后关系的系统评价与Meta分析. 中国胸心血管外科临床杂志, 2019, 26(7): 625-632.
|
| 11. |
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002, 21(11): 1539-1558.
|
| 12. |
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997, 315(7109): 629-634.
|
| 13. |
Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer, 2004, 108(1): 115-121.
|
| 14. |
Swerdlow AJ, Laing SP, Qiao Z, et al. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer, 2005, 92(11): 2070-2075.
|
| 15. |
Ogunleye AA, Ogston SA, Morris AD, et al. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer, 2009, 101(7): 1199-1201.
|
| 16. |
Hemminki K, Li X, Sundquist J, et al. Risk of cancer following hospitalization for type 2 diabetes. Oncologist, 2010, 15(6): 548-555.
|
| 17. |
Atchison EA, Gridley G, Carreon JD, et al. Risk of cancer in a large cohort of U. S. veterans with diabetes. Int J Cancer, 2011, 128(3): 635-643.
|
| 18. |
Joh HK, Willett WC, Cho E. Type 2 diabetes and the risk of renal cell cancer in women. Diabetes Care, 2011, 34(7): 1552-1556.
|
| 19. |
Zhang PH, Chen ZW, Lv D, et al. Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China. BMC Public Health, 2012, 12: 567.
|
| 20. |
Lin CC, Chiang JH, Li CI, et al. Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan. BMC Cancer, 2014, 14: 381.
|
| 21. |
Tseng CH. Type 2 Diabetes mellitus and kidney cancer risk: a retrospective cohort analysis of the national health insurance. PLoS One, 2015, 10(11): e0142480.
|
| 22. |
Wang M, Hu RY, Wu HB, et al. Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China. Sci Rep, 2015, 5: 11503.
|
| 23. |
Graff RE, Sanchez A, Tobias DK, et al. Type 2 diabetes in relation to the risk of renal cell carcinoma among men and women in two large prospective cohort studies. Diabetes Care, 2018, 41(7): 1432-1437.
|
| 24. |
Kim SK, Jang JY, Kim DL, et al. Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea. Korean J Intern Med, 2020, 35(3): 641-651.
|
| 25. |
Undzyte G, Patasius A, Linkeviciute-Ulinskiene D, et al. Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania. Aging Male, 2020, 23(5): 1241-1245.
|
| 26. |
Wang S, Lo Galbo MD, Blair C, et al. Diabetes and kidney cancer risk among post-menopausal women: The Iowa women's health study. Maturitas, 2021, 143: 190-196.
|
| 27. |
Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer, 2008, 8(12): 915-928.
|
| 28. |
Ibrahim YH, Yee D. Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res, 2004, 14(4): 261-269.
|
| 29. |
Oya M. Renal cell carcinoma: biological features and rationale for molecular-targeted therapy. Keio J Med, 2009, 58(1): 1-11.
|
| 30. |
Stadler W, Vogelzang NJ. Human renal cancer carcinogenesis: a review of recent advances. Ann Oncol, 1993, 4(6): 451-462.
|
| 31. |
杨浩森, 双卫兵, 仝煦楠. 糖尿病与肾癌的相关性研究. 转化医学电子杂志, 2018, (1): 35-38.
|
| 32. |
Morss AS, Edelman ER. Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem, 2007, 282(19): 14635-14644.
|
| 33. |
Masur K, Vetter C, Hinz A, et al. Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation. Br J Cancer, 2011, 104(2): 345-352.
|
| 34. |
Ogushi T, Takahashi S, Takeuchi T, et al. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma. Cancer Res, 2005, 65(9): 3700-3706.
|
| 35. |
Attner B, Landin-Olsson M, Lithman T, et al. Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden. Cancer Causes Control, 2012, 23(5): 769-777.
|
| 36. |
Sakowicz-Burkiewicz M, Pawelczyk T. Recent advances in understanding the relationship between adenosine metabolism and the function of T and B lymphocytes in diabetes. J Physiol Pharmacol, 2011, 62(5): 505-512.
|
| 37. |
Bao C, Yang X, Xu W, et al. Diabetes mellitus and incidence and mortality of kidney cancer: a meta-analysis. J Diabetes Complications, 2013, 27(4): 357-364.
|
